8102
-
OncoTargets and Therapy
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
OncoTargets and Therapy
(347,931) Views
Editor in Chief Professor Hans-Joachim Schmoll
1178-6930
ReviewSurvivin-T34A: molecular mechanism and therapeutic potential
Jonathan R Aspe, Nathan R Wall
OncoTargets and Therapy 2010, 3:247-254
06 December 2010
Review
The spectrum of use of rituximab in chronic lymphocytic leukemia
Alessandra Tedeschi, Eleonora Vismara, Francesca Ricci, et al
OncoTargets and Therapy 2010, 3:227-246
26 November 2010
Original Research
Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells
Borhane Annabi, Eric Vaillancourt-Jean, Alexander G Weil, et al
OncoTargets and Therapy 2010, 3:219-226
15 November 2010
Original Research
Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial
Peter D Beitsch, Rakesh R Patel, John D Lorenzetti, et al
OncoTargets and Therapy 2010, 3:211-218
29 October 2010
Perspectives
Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics
Kimbach Tran Carpiuc, Gianantonio Rosti, Fausto Castagnetti, et al
OncoTargets and Therapy 2010, 3:205-210
11 October 2010
Original Research
Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study
William C Dooley, John P Thropay, Gary J Schreiber, et al
OncoTargets and Therapy 2010, 3:197-203
21 September 2010
Review
Profile of temsirolimus in the treatment of advanced renal cell carcinoma
Michael Staehler, Nicolas Haseke, Wael Khoder, et al
OncoTargets and Therapy 2010, 3:191-196
15 September 2010
Review
The bevacizumab experience in advanced renal cell carcinoma
Lauren C Harshman, Sandy Srinivas
OncoTargets and Therapy 2010, 3:179-189
15 September 2010
Review
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
Nousheen Samad, Anas Younes
OncoTargets and Therapy 2010, 3:167-178
06 September 2010
Review
Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine
Steven E McCormack, Erica D Warlick
OncoTargets and Therapy 2010, 3:157-165
22 July 2010
Review
New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib
C Lance Cowey, Guru Sonpavde, Thomas E Hutson
OncoTargets and Therapy 2010, 3:147-155
20 September 2010
Review
Temozolomide in malignant glioma
Gregor Dresemann
OncoTargets and Therapy 2010, 3:139-146
21 July 2010
Original Research
Dynamic changes to survivin subcellular localization are initiated by DNA damage
Maritess Gay Asumen, Tochukwu V Ifeacho, Luke Cockerham, et al
OncoTargets and Therapy 2010, 3:129-137
01 July 2010
Review
Current and emerging therapies for the treatment of pancreatic cancer
Rebecca A Moss, Clifton Lee
OncoTargets and Therapy 2010, 3:111-127
14 July 2010
Review
A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency
Mariam Hammadi, Jacques-Olivier Pers, Christian Berthou, et al
OncoTargets and Therapy 2010, 3:99-109
15 June 2010
Review
The dual kinase complex FAK-Src as a promising therapeutic target in cancer
Victoria Bolós, Joan Manuel Gasent, Sara López-Tarruella, et al
OncoTargets and Therapy 2010, 3:83-97
15 June 2010
Review
Anti-angiogenesis therapies: their potential in cancer management
Andrew Eichholz, Shairoz Merchant, Andrew M Gaya
OncoTargets and Therapy 2010, 3:69-82
04 May 2010
Review
First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab
Carmen Diana Schweighofer, Clemens-Martin Wendtner
OncoTargets and Therapy 2010, 3:53-67
30 March 2010
Review
Update on options for treatment of metastatic castration-resistant prostate cancer
Prakash Vishnu, Winston W Tan
OncoTargets and Therapy 2010, 3:39-51
23 March 2010
Review
New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab
Argirios Moustakas, Teri N Kreisl
OncoTargets and Therapy 2010, 3:27-38
11 March 2010
Review
CTLA-4 blockade: therapeutic potential in cancer treatments
Ahmad A Tarhini, Fatima Iqbal
OncoTargets and Therapy 2010, 3:15-25
01 March 2010
Review
An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
Jacqueline S Garcia, Nitin Jain, Lucy A Godley
OncoTargets and Therapy 2010, 3:1-13
25 February 2010
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Intranet access to all Dove journals
If you would like your institutional intranet to have access to the Dove Medical Press journals please contact me.
